Representative Kevin Hern disclosed the sale of his entire position in UnitedHealth Group ($UNH), worth between $250,001 and $500,000, according to a newly filed Periodic Transaction Report, following congressional testimony this week by UnitedHealth’s chief executive and other healthcare leaders.
- The filing shows a sale of UnitedHealth common stock on December 23, 2025, with notification made on December 24, 2025.
- The transaction was reported as “sell to close” and attributed to a subholding of the Hern Family Revocable Trust.
- Hern represents Oklahoma’s 1st District and serves on the House Ways and Means Subcommittee on Health.
- The disclosure follows a House Energy and Commerce Subcommittee on Health hearing focused on health insurance affordability.
- UnitedHealth CEO Stephen Hemsley testified alongside executives from CVS Health, Elevance Health, and Cigna.
- Earlier this week, UnitedHealth said it plans to rebate profits from its Affordable Care Act exchange plans in 2026.
Relevant Companies
- UnitedHealth Group ($UNH) – Subject of the disclosed stock sale and recent congressional testimony on health costs and ACA-related policies.
Editor’s Note: This is a developing story. This article may be updated as more details become available.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/Microsoft%20Corporation%20logo%20on%20sign-by%20Jean-Luc%20Ichard%20via%20iStock.jpg)
/ServiceNow%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)